Sports concussion research funded at University of Pennsylvania

University of Pennsylvania has won funding for a study of a concussion treatment for athletes.Dr. Peter LeRoux, associate professor of neurosurgery, won the$250,000, three-year Dana Foundation Clinical Neuroscience grant.Dr. Akiva S. Cohen is an associate professor of neurology, neurosurgery and pediatrics at Penn’s Perelman School of Medicine and the Children’s Hospital of Philadelphia. Cohen and [...]

[Read more of this report]


Cornerstone Therapeutics acquires Cardiokine; NDA filed prior to deal

Respiratory treatments company Cornerstone Therapeutics (NASDAQ:CRTX) is broadening its offerings with the acquisition of cardiovascular drug company Cardiokine Biopharma.Cary, North Carolina-based Cornerstone’s acquisition of Cardiokine, located in Philadelphia, was completed on Dec. 30, a day after Cardiokine filed a New Drug Application (NDA) for its lead drug candidate, lixivaptan.AdvertisementLixivaptan has completed phase 3 clinical trials [...]

[Read more of this report]


10 startups from mHealth 2011: OrganizedWisdom

The experience of having surgery can be a stressful and sometimes frightening prospect for patients. New York-based OrganizedWisdom’s program enables physicians to deepen patient understanding of complex surgical procedures with diagrams, videos and information that can be viewed at home and with a patient’s smartphone. The company’s chief medical officer, Dr. Howard Krein, is an assistant professor of otolaryngology, head and neck surgery, at Thomas Jefferson University Hospital in Philadelphia and a founding partner and co-director of Jefferson’s Herbert Kean Center for Facial Aesthetics.

[Read more of this report]


10 startups from mHealth 2011: Ayogo

Gaming is a big trend in health IT and mobile health in particular as a way to help patients follow a health regimen and make healthier choices. Ayogo’s gaming software targets people with chronic diseases and encourages them to share their day-to-day progress with stories.

[Read more of this report]


Shire agrees to more clinical trials for blood pressure drug, but threat of FDA action lingers

One year after Shire (NASDAQ:SHPGY) pulled its drug for low blood pressure, ProAmatine, from the market after reaching an impasse with the U.S. Food and Drug Administration, it has agreed to do the additional clinical tests the regulator wanted.The agreement was made with the Center for Drug Evaluation and Research, a division of the FDA. [...]

[Read more of this report]


MedCityNews.com heads East: Welcome Philadelphia

Ask a person on any street in America about medical innovations and you’ll get answers like Boston, San Francisco and the Twin Cities. It’s stunning that same national cachet is less often attached to the MedCity of Philadelphia.In recent years, there’s been much more buzz. A Milken study funded by regional groups a couple years [...]

[Read more of this report]


After $3B federal settlement, GSK pressured to settle Avandia patient suits

A week after GlaxoSmithKline (NYSE:GSK) reached a $3 billion federal settlement over claims it illegally marketed Avandia and other drugs, the drugmaker now faces pressure to resolve the thousands of Avandia patient lawsuits that remain.Judge Cynthia Rufe, U.S. district judge for the Eastern District of Pennsylvania, appointed a mediator to oversee settlement negotiations for Avandia [...]

[Read more of this report]


Penn Medicine to expand use of EMR software to find clinical trial candidates

Penn Medicine is moving ahead with a tool that flags candidates for clinical trials in its electronic medical record systems after finishing a successful pilot program that drove clinician referrals.Penn Medicine is doing a second pilot with its Penn Research Trial Advisory software that includes two more clinical trials. The software is programmed to look [...]

[Read more of this report]


5 mistakes companies make launching drugs, medical devices

So, you not only come up with a great medical device or drug that will improve or save lives, you spend years getting your product through clinical trials. And, finally, it’s approved by the U.S. Food and Drug Administration. Now, your product is ready to launch.But one major issue highlighted at a panel discussion at [...]

[Read more of this report]


Biotech forum offers stage for new and mature entrepreneurs

The Innovation Forum at the Biotech 2011 conference in Philadelphia this week sought to put scientists and early stage startups from universities and incubators in the region in front of investors and alongside other, more mature startups to provide opportunities for investment and partnerships.Judith Sheft, associate vice president for technology and development at the New [...]

[Read more of this report]


Older Posts »

Be a Thought Leader: Join MedCitizens

Anyone can blog on MedCity News when they become a "MedCitizen." MedCitizens publish their own thoughts about current medical news and the latest issues in healthcare to the entire MedCity News audience.

Click to login or learn more

MedCity Twitter Buzz

MedCity Jobs Board

Real Time Web Analytics